Core Viewpoint - Several newly established funds that had remained inactive for a month began to build positions on April 7, indicating a shift in market sentiment towards fundamentals and performance-driven strategies [3][6]. Group 1: Fund Activity - Multiple new fund products, which had maintained a net value of zero fluctuation for a month, started to show a net value change of approximately 1% to 2% on April 7, coinciding with market adjustments [3]. - The Guangfa Tongyuan Return Fund, established on March 6, raised 18.91 billion units in just two days, making it the largest actively managed equity fund issued this year [4]. - The Kai Stone Yuanxin Mixed Fund and the Nanhua Fengli Quantitative Stock Selection Fund also began buying stocks on April 7 after a month of maintaining near-zero net value fluctuations [5]. Group 2: Market Dynamics - The market adjustment on April 7 catalyzed a transition from concept-driven to performance-driven strategies, with a strong rebound observed on April 8 [6]. - Stocks in the medical device sector, particularly those with domestic brand advantages, became key targets for institutional investment, with significant price increases noted on April 8 [7]. - Companies with a focus on domestic markets, such as Hui Tong Da Network, emphasized their lack of overseas business to mitigate investor concerns regarding external risks [7]. Group 3: Investment Opportunities - Fund managers expressed confidence in long-term market positioning, highlighting investment opportunities in sectors like technology, consumer goods, and healthcare [9]. - The market's response to policy measures and the potential for domestic consumption stimulus were seen as factors that could support stock market stability and growth [11]. - The domestic medical device and pharmaceutical sectors are viewed as attractive investment areas, particularly in light of rising costs for imported products [12].

Core Viewpoint - The recent trend of early fundraising closures for new funds indicates a warming market, with increased investor enthusiasm and a shift from cautious observation to active participation [1][4]. Fundraising Market Recovery - Multiple new fund products have completed fundraising ahead of schedule, reflecting a significant increase in investor confidence as the domestic stock and bond markets stabilize [3][4]. - Since March, over ten funds have ended their fundraising early, including low-risk products like bond funds and various equity funds, showcasing a diverse product offering [3]. Focus on Technology Innovation Funds - Technology-focused funds, particularly ETFs, have seen remarkable demand, with several products like the Huatai-PB SSE Sci-Tech Innovation Board 200 ETF completing fundraising quickly [6][9]. - The surge in interest for technology funds is attributed to improved market sentiment and a growing recognition of the investment logic in the tech sector, especially in areas like artificial intelligence [6][10]. Investor Preferences and Strategies - Investors are increasingly favoring short- to medium-term bond funds due to their clear cash flow expectations and liquidity, aligning with current risk preferences [7]. - ETFs are becoming the primary tool for investors to access the Sci-Tech sector, offering low costs, high efficiency, and risk diversification, making them attractive for capturing long-term growth opportunities [9][10].